成都愛興生物科技有限公司（簡稱愛興生物）成立于2013年4月，由在IVD領域耕耘超過二十年的海外科學家創建，團隊吸引了行業內資深專家、管理精英加盟。公司坐落在四川省成都市郫都區融智創新產業園，擁有現代化的研發實驗室和完善的配套設施。
愛興生物是一家專注于即時診斷（POCT）技術領域的創新型生物高科技企業。我們的愿景是“創新讓生命之樹長青“，我們將逐步開發更多創新產品，積極為中國醫療衛生事業做出貢獻。
公司擁有自主知識產權的“IXING POCT“技術平臺，主打產品IXHOMO i120和IXHOMO i960是創新的均相化學發光POCT產品，具有完全自主知識產權，相對于傳統化學發光技術，一方面免除了復雜的磁珠清洗步驟，另一方面也不需要加入昂貴的底物或發光啟動試劑，除了具有傳統化學發光方法靈敏度高、信號范圍寬等優點，還具有非常優異的精密度。徹底顛覆傳統POCT產品“快而不精、快而不準”的形象，引領POCT進入“精準”新時代！
Founded in 2013 by oversea scientists with rich R&D and management experience, Chengdu IXING Biotechnology Co., Ltd. (IXING) is a high-tech innovative IVD company focused on precise POCT technology platform and products. We have two R&D centers in Chengdu and Shanghai, respectively.
Our vision is "more innovation, more health". We believe our innovative technologies and products will contribute to the healthcare industry of China.
IXING has its own intellectual property for its "IXING POCT" platform. IXHOMO i120 and IXHOMO i960 are the innovative POCT products based on homogeneous chemiluminescence principle. And we have also applied for patents for our technologies and products. Compared to the traditional chemiluminescence technologies, on the one hand we don't need the expensive magnetic particles and substrates or trigger reagents, on the other hand washing steps are not required completely. So our customers can get not only high sensitivity but also an excellent precision easily. Our products will redefine POCT and lead POCT into "precision times".
